PFIZER’s ZOLOFT U.S. SALES NEAR $175 MIL. IN FIRST YEAR ON MARKET; PRICE REDUCTION COULD BE RESPONSE TO PAXIL LAUNCH; NORVASC OFF TO "GREAT START"

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".